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The dorsal medial prefrontal (anterior cingulate) 
cortex–amygdala aversive ampliﬁ cation circuit in 
unmedicated generalised and social anxiety disorders: 
an observational study
Oliver J Robinson, Marissa Krimsky, Lynne Lieberman, Phillip Allen, Katherine Vytal, Christian Grillon
Summary
Background In four previous studies, we have delineated the role of positive circuit coupling between the dorsal medial 
prefrontal (anterior cingulate) cortex and the amygdala during aversive processing in healthy people under stress. This 
translational circuit—the aversive ampliﬁ cation circuit—is thought to drive adaptive, harm-avoidant behaviour in 
threatening environments. We assess the role of this circuit in the pathological manifestation of anxiety disorders.
Methods For this single-site study, 45 unmedicated participants (22 with generalised and/or social anxiety disorder and 
23 healthy controls) were recruited via advertisements from the metropolitan area of Washington, DC (USA). People who 
applied to participate in the study had to pass an initial telephone screen and comprehensive screening by a clinician at 
the National Institutes of Health (NIH; Bethesda, MD, USA). People with a contraindicated medical disorder, past or 
current psychiatric disorders other than anxiety disorders, and those using psychoactive medications or illicit drugs were 
excluded. Eligible individuals could participate as either a healthy control or a patient, depending on diagnosis. They were 
asked to use a button box to complete a simple emotion identiﬁ cation task (fearful vs happy faces; 44 trials of each) 
during functional MRI at the NIH. Functional imaging analysis consisted of event-related activation analysis and 
psychophysiological interaction connectivity analysis of regions coupled with the amygdala during task performance.
Findings A diagnosis-by-valence interaction was recorded in whole-brain amygdala connectivity within the dorsal 
medial prefrontal (anterior cingulate) cortex clusters identiﬁ ed in our previous study, driven by signiﬁ cantly increased 
circuit coupling during processing of fearful faces versus happy faces in anxious, but not healthy, participants. 
Importantly, and in accordance with contemporary theoretical approaches to psychiatry, circuit coupling correlated 
positively with self-reported anxious symptoms, which provides evidence of a continuous association between the 
circuit and subjective symptoms.
Interpretation In this study and our previous work, we track the functional role of one neural circuit from its 
involvement in adaptive threat biases under stress, to its chronic engagement in anxiety disorders in the absence of 
experimentally induced stress. Thus, we uniquely map a mood and anxiety-related circuit across its adaptive and 
maladaptive stages. Clinically, this study could provide a step towards a more mechanistic continuum-based approach 
to anxiety disorder diagnosis and might ultimately lead to more targeted treatments for patients with anxiety disorders.
Funding National Institute of Mental Health, USA, and Medical Research Council 
Copyright © Robinson et al. Open Access article distributed under the terms of CC BY.
Introduction
Pathological anxiety is a large and increasing global 
health problem.1 People with the disorder go through 
periods of crippling anxiety that adversely aﬀ ect their 
daily lives. One of the key contributing symptoms is a 
persistent and debilitating focus upon negative or 
potentially threatening life experiences.1 This negative 
aﬀ ective bias can be experimentally quantiﬁ ed as 
increased threat processing at the neural, psychological, 
and behavioural levels.1 
However, anxiety can also be an adaptive process 
that improves an individual’s ability to avoid harm. 
Indeed, negative aﬀ ective biases towards threats are 
recorded in healthy people experiencing transient 
anxiety or stress.1 The adaptive and maladaptive 
anxiety-driven negative aﬀ ective biases might be 
linked, perhaps falling at opposite ends of the same 
scale. Such an association would have implications for 
how we diagnose and treat these disorders, but 
evidence is scarce at present. This study therefore 
extends four of our previous studies mapping the 
circuit-based interactions between the dorsal medial 
prefrontal (anterior cingulate) cortex and the amygdala 
during adaptive threat processing in stressed healthy 
people to address pathological anxiety.
The role of the amygdala in threat processing is well 
known,2–4 but the various regions of the brain do not 
respond in isolation—rather, they constitute nodes in 
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complex neural circuits.5,6 Our recent work has therefore 
begun to outline how interactions between the amygdala 
and higher cortical regions contribute towards threat-
processing biases. In particular, our work suggests that 
interactions between the dorsal medial prefrontal 
(anterior cingulate) cortex and amygdala constitute an 
aversive-ampliﬁ cation circuit whereby increased positive 
coupling between these regions is associated with 
increased threat processing under stress.7–9 Notably, this 
role, derived from translational animal research,10 is 
thought to be distinct from a more frequently studied 
reciprocal, opposing inhibitory role11,12 of adjacent ventral 
(and subgenual) regions of the prefrontal and cingulate 
cortex (discussed in more detail elsewhere13–15).
Speciﬁ cally, we have shown that stress induced by a 
threat of shock in healthy people (a manipulation in which 
participants are told they might potentially receive a shock 
and that reliably increases psychological, physiological, 
cognitive, and neural concomitants of stress1) drives 
increased attentional bias (in a face emotion identiﬁ cation 
task) to fearful faces16 as a function of increased positive 
functional connectivity between the dorsal medial 
prefrontal (anterior cingulate) cortex and the amygdala 
(ﬁ gure 1).7 Second, we have replicated this ﬁ nding using a 
diﬀ erent technique, task-independent resting state fMRI; 
enhanced positive endogenous connectivity (ie, oscillatory 
connectivity during rest periods with no task) is recorded 
between the dorsal medial prefrontal (anterior cingulate) 
cortex and the amygdala during prolonged periods of 
threat of shock in an adapted resting-state paradigm in 
healthy participants.9 Third, we have shown that threat of 
shock leads to cognitive disturbances in working memory 
in healthy people1 that are also associated with increased 
coupling within this circuit (Vytal K, unpublished). Finally, 
we have reported that mimicking a pharmacological 
symptom of anxiety in healthy individuals—reduced 
serotonergic function—engages functional connectivity 
within this same circuit during processing of fearful faces.8 
This fourth study provides a putative mechanism by which 
selective serotonergic reuptake inhibitor drugs might, 
through modulation of this circuit, alleviate anxiety.8
Thus, we have comprehensively mapped the workings 
of this circuit in healthy people. Therefore, the main goal 
of the present study is to provide experimental evidence 
that this functionally mapped circuit might have a key 
role in pathological anxiety disorders. Previous work 
focusing on threat processing in anxiety disorders has 
shown abnormal activity in regions of the prefrontal 
cingulate cortex and the amygdala.17–19 However, studies 
so far have mostly assessed individual region activations 
(ie, the change in the activity of a region in one condition 
vs another), and not circuitry (ie, the extent to which 
activity correlates between two regions in one condition 
vs another). Correlation between regions is thought to at 
least partly represent ﬂ ow of information between them, 
and can be seen in the absence of activation changes (for 
more details, see elsewhere20). Such between-region 
interactions therefore provide better insight into the way 
these regions act as a circuit.
Psychiatric disorders are increasingly recognised to be 
unlikely to fall within the categorical (ie, healthy/unwell) 
diagnoses of existing diagnostic criteria, but rather lie 
along a scale from more “normal” to more “impaired” 
function (for more details, see elsewhere21). Our previous 
studies showed that activation of the dorsal medial 
prefrontal (anterior cingulate) cortex and amygdala circuit 
falls along a continuous dimension as a function of trait 
anxiety symptoms,7,9 with increased trait feelings of 
anxiety (a vulnerability factor for anxiety disorders) being 
associated with greater positive coupling within this 
circuit. This ﬁ nding generates a secondary prediction: 
pathological anxiety symptoms will also fall along this 
continuum. This theory suggests that anxiety symptoms 
that are severe enough to interfere with daily living should 
be associated with even more circuit engagement along 
the same dimensional index. Such a ﬁ nding would, from 
a clinical perspective, help to refocus our understanding 
of anxiety disorders away from discrete diagnoses and 
towards more of a range or scale.
Methods
Study design and participants
We did this single-site study at the National Institutes of 
Health (NIH) Clinical Center in Bethesda (MD, USA). 
Participants were recruited from the Washington DC 
metropolitan area (USA) for the study by ﬂ yers and 
advertisements placed in local newspapers. One line of 
recruitment sought participants who had anxiety 
For regions of interest see 
http://ﬁ gshare.com/authors/
Oliver_Robinson/568652
Figure 1: Regions of interest derived from our study using threat of shock as 
a stress induction in healthy participants7
Both a posterior cluster encompassing dorsal anterior cingulate and medial 
prefrontal cortex (dorsal region highlighted in dark pink) and a rostral cluster in 
the dorsal medial prefrontal cortex (rostral region highlighted in green ) showed 
increased positive connectivity with the amygdala during the processing of 
fearful faces under stress and were used to create regions of interest for the 
present study. These regions of interest are freely available to download online.
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problems whereas another line did not specify psychiatric 
issues. Following an initial telephone screen, participants 
visited the NIH for comprehensive screening by a 
clinician, which comprised a physical examination, 
urine screen, and a Structured Clinical Interview [SCID] 
from the Diagnostic and Statistical Manual of Mental 
Disorders [DSM], Fourth Edition.22 Exclusion criteria 
were: contraindicated medical disorder; past or current 
psychiatric disorders other than anxiety disorders; and 
use of psychoactive medications or illicit drugs (as tested 
by the urine screen). People who passed this screening 
stage were given the option to participate in the study as 
either a healthy control or a patient (depending on their 
diagnosis). Participants completed measures of anxiety 
(State-Trait Anxiety Inventory [STAI]23,24), depression 
(Beck Depression Inventory [BDI]24), and intelligence 
quotient (Wechsler Abbreviated Scale of Intelligence 
[WASI]25). Five patients were excluded because of scan 
acquisition artifacts (eg, caused by extreme movements 
or scanner malfunction); therefore, the ﬁ nal sample 
consisted of 45 unmedicated people, 22 of whom were 
suﬀ ering from a current anxiety disorder. 15 of these 
patients had a generalised anxiety disorder, of which 
nine were comorbid with a secondary diagnosis of social 
anxiety disorder; and seven had a social anxiety disorder. 
23 healthy controls also participated. In the patients with 
anxiety disorders, the mean estimated illness duration 
was 16 (SD 8) years. Seven patients had received previous 
pharmacological treatment, which had been discontinued 
(>10 years ago [n=5], >6 months ago [n=1], or >2 months 
ago [n=1]). Unmedicated status was necessary to avoid 
potential drug-linked vascular confounders. Patients 
and healthy controls were matched for demographic 
variables (table 1). All participants provided written 
informed consent that was approved by the Combined 
Neuroscience Institutional Review Board of the NIH.
Procedures
For their task in this study, participants were asked to 
use a button box to identify whether faces16 were fearful 
or happy. The task consisted of 88 trials (44 fearful faces 
and 44 happy faces) with 2000–4000 ms jitter between 
the trials. Each stimulus was presented for 990 ms and 
30 s of ﬁ xation was presented at the start and end of the 
task. This task is the same as that used previously in 
healthy controls7 but without the concurrent threat of 
shock stress manipulation used in that previous study. 
Participants were asked to respond as quickly as 
possible using a button box placed upon their abdomen 
in the scanner. The task was projected on a screen to 
the rear of the scanner, visible by means of a mirror 
attached to the head coil (an integral component of the 
fMRI scanner).
We used a 3T Skyra scanner (Siemens, Malvern, PA, 
USA) to acquire one 207 volume acquisition echo planar 
imaging (EPI) sequence (ﬂ ip angle 70°; repetition time 
[TR] 2000 ms; echo time [TE] 30 ms; ﬁ eld of view [FOV] 
100 cm; slice thickness 3 mm; matrix 64 × 64 samples 
sagittal). We discarded the ﬁ rst ﬁ ve volumes from each 
run to allow for scanner equilibration. The structural 
sequence comprised a magnetisation-prepared rapid 
gradient echo anatomical reference image (ﬂ ip angle 9°; 
TR 1900 ms; TE 2·1; inversion time 450 ms; FOV 100 cm; 
slice thickness 0·9 mm; matrix 256 × 256). We preprocessed 
and analysed images using SPM version 8. SPM refers to 
the “conjoint use of the general linear model (GLM) and 
Gaussian random ﬁ eld (GRF) theory to analyse and make 
classical inferences about spatially extended data through 
statistical parametric maps (SPMs)” (for SPM software 
information, see online).
Statistical analysis 
Our analyses consisted of ﬁ ve well-established steps, the 
ﬁ rst of which was preprocessing to transform the blood-
oxygen level-dependent (BOLD) signal acquired during 
scanning into the same standardised space across time 
and across all participants. Step two was statistical 
activation analysis to generate BOLD signal activation 
estimates for each trial type (fearful vs happy faces) for 
each participant (ﬁ rst-level event-related analysis with 
use of mass univariate general linear models). The third 
step was statistical connectivity analysis to estimate 
which regions across the whole brain are signiﬁ cantly 
associated with the BOLD activity recorded in the 
amygdala during each trial type (a psychophysiological 
interaction analysis). Fourth was a group-level analysis 
in which summary estimates of activation or connectivity 
for each participant are compared across groups (second-
level analysis with t tests). The ﬁ fth step was a group-
level continuous variable analysis in which summary 
estimates of activation or connectivity for each participant 
are correlated with individual diﬀ erence measures (eg, 
trait personality scales or mean reaction times).
Preprocessing consisted of within -participant realign-
ment, coregistration, segmentation, normalisation, and 
smoothing (with a Gaussian kernel 8 mm full width at 
half maximum). In an event-related analysis, we used a 
Anxiety 
disorders 
(n= 22)
Healthy controls 
(n=23)
F test 
value
p value
Demographics
Female sex 16 (73%) 14 (61%) ·· ··
Age (years) 28 (8) 28 (6) 0·04 0·9
Questionnaire measures on day of scan
WASI 118 (10) 119 (10) 0·2 0·6
STAI state 40 (12) 25 (4) 33 <0·0001
STAI trait 49 (12) 26 (5) 71 <0·0001
BDI 9 (9) 0·7 (1) 21 <0·0001
Data are n (%) or mean (SD). All participants were right handed except for one patient 
and one healthy control who were left handed. WASI=Wechsler Abbreviated Scale of 
Intelligence. STAI=State-Trait Anxiety Inventory. BDI=Beck Depression Inventory.
Table 1: Baseline characteristics
For SPM software information 
see http://www.ﬁ l.ion.ucl.ac.uk/
spm/doc/intro
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general linear model to estimate the BOLD signal change 
associated with the onset times of each face valence 
(fearful or happy). We also included motion parameters 
created during the realignment phase as nuisance 
regressors in this model (to account for noise associated 
with participant movement). This process was repeated 
for each participant and asks: what is the BOLD signal 
change associated with fearful and happy faces? 
We then created a generalised psychophysiological 
interaction general linear model for each participant in 
the same manner as in our previous studies7,8 (which 
were distinct studies for which the sample populations 
were recruited separately). Speciﬁ cally, we used SPM8 
code to generate the following regressors from the event-
related model described above: an eigenvariate summary 
of BOLD signal localised within spatial conﬁ nes of the 
amygdala seed used in our previous study7 (an anatomical 
region of interest [ROI] deﬁ ned by an automated 
anatomical labelling library26) across time; separate 
psychological regressors representing the onsets of each 
happy face and each fearful face; and psychophysiological 
interaction terms representing the interaction between 
the ﬁ rst two regressors. Next, we created a general linear 
model for each participant in which we included one 
regressor representing a deconvolved BOLD signal 
alongside each psychological and psychophysiological 
interaction term for each event type. This model 
therefore asks: for each participant, which regions of the 
brain show a BOLD signal that is signiﬁ cantly associated 
with that of the amygdala during the events of interest 
(fearful or happy)? This is the circuit-coupling measure 
that we are interested in. 
For each participant, we then created a contrast 
representing the regions across the whole brain that were 
more strongly related with the amygdala during fearful 
face processing than during happy face processing (ie, 
fearful vs happy contrast). We compared these within-
participant contrasts at the group level in a standard SPM8 
two-sample (healthy vs anxious) t test. This analysis 
provided us with an estimate of regions, across the whole 
brain, that showed greater correlation with the amygdala 
in anxious patients than in healthy controls during fearful 
(compared with happy) face processing (ie, a diagnosis-by- 
valence interaction). We did similar analyses for event-
related activations of each trial versus baseline. 
To directly compare cross-study activation with our 
previous study, we created a priori ROIs from the 
clusters in our ﬁ rst study7 (ﬁ gure 1) using the “get SPM 
cluster” function of the MARSBAR toolbox for SPM8.27 
These clusters were generated at a threshold of p<0·001 
(uncorrected) in our previous data from the within-
participant, whole-brain threat-by-valence interaction 
map generated by use of the ﬂ exible factorial model in 
SPM8 (for more details, see the original report27 or 
download the ROIs from the internet). This ROI 
comprised the largest, more dorsal and posterior peak 
dorsal medial prefrontal cortex–dorsal anterior cingulate 
cortex cluster (referred to as dorsal from now on) and a 
more rostral dorsal medial prefrontal cortex area 
(referred to as rostral from now on). Activations that fall 
within these regions in the group analyses of the present 
study can be said to overlap with the activation in our 
previous study. 
We report Montreal Neurological Institute (MNI) 
standardised coordinates28 (denoted as x,y,z). For additional 
corroboration, we extracted the activation and connectivity 
estimates (betas) from the peak voxel (x,y,z=2,2,40) from 
our previous study. We then analysed these extracted betas 
using general linear models in SPSS version 22.
We did continuous variable functional MRI analyses 
by separately correlating STAI trait anxiety24 (measured 
on the day of testing) and behavioural bias (fearful 
minus happy reaction times) with the fearful face versus 
happy face connectivity estimates derived from the 
connectivity analysis. This analysis therefore asks, across 
the whole sample or within groups, which connectivity 
estimates (across the whole brain) are signiﬁ cantly 
associated with the bias or trait anxiety variables?
For ROIs see http://ﬁ gshare.com/
authors/Oliver_Robinson/568652
Figure 2: Categorical analysis
(A) A whole-brain diagnosis-by-valence interaction in dorsal anterior cingulate 
cortex–amygdala connectivity was recorded with yellow areas indicating 
increased circuit activity during observation of fearful versus happy faces in 
patients. (B) Fearful face versus happy face connectivity in healthy controls and 
patients with anxiety disorders; data extracted for illustrative purposes from the 
a priori peak (x,y,z=2,2,40). 
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We established upper and lower value boundaries for 
outliers by use of the formula Q3 ± (2·2 × [Q3 – Q1]),29 in 
which Q3 is the third quartile and Q1 is the ﬁ rst quartile. 
All extreme values fall within the bounds for outliers 
(–0·4 to 96·4 for trait anxiety and –2·6 to 4·8 for 
connectivity betas); hence, no participants were excluded. 
Interactions of interest were signiﬁ cant at p<0·05 
familywise error rate (FWE), corrected for multiple 
comparisons, both across the whole brain and within our 
a priori ROIs. Additional analyses are reported at p<0·001 
uncorrected when they are of a priori relevance. Findings 
below these thresholds are judged to be non-signiﬁ cant.
Role of the funding source
The funder had no input in study design; in the 
collection, analysis, or interpretation of data; in the 
writing of the report; or in the decision to submit for 
publication. OJR, LL, KV, PA, and CG had access to all 
the study data. CG had ﬁ nal responsibility for the 
decision to submit for publication.
Results
The diagnosis-by-valence interaction analysis showed, as 
postulated, a whole-brain peak amygdala connectivity with 
the dorsal medial prefrontal (anterior cingulate) cortex 
(peak x,y,z=4,–8,32; t=4·69; p[FWE corrected]=0·0289; 
ﬁ gure 2A, table 2). Analyses of this connectivity with use of 
an ROI generated from the largest ROI cluster (dorsal) 
from our previous study (ﬁ gure 1) showed signiﬁ cant 
overlap across studies (peak x,y,z=4,–8,32; t=4·43; p[FWE 
corrected]=0·001). We recorded the same pattern at a non-
signiﬁ cant threshold in an ROI generated from the rostral 
cluster (peak x,y,z=14,40,42; t=3·44; p[uncorrected]<0·0006).
Breakdown of this interaction into groups (control/
patient) and valence (fear/happy) showed a signiﬁ cant 
a priori increase in fear versus happy activation in 
anxious patients (dorsal: peak x,y,z=14,4,36; t=4·0; 
p[uncorrected]=0·0008), but not in healthy controls 
(dorsal: p[uncorrected]>0·15). Betas extracted from the 
peak voxel from our previous study (x,y,z=2,2,40) for 
illustrative purposes showed that this diagnosis-by-
valence interaction (F[degrees of freedom 1,43]=5·3, 
p=0·03; ﬁ gure 2B) was driven by increased coupling 
during the processing of fearful faces versus happy faces 
in patients with anxiety disorders (t[21]=2·2, p=0·039), 
but not healthy controls (p=0·2). 
This fear versus happy connectivity increased as a 
function of trait anxiety along a continuum across the 
sample as a whole (whole-brain peak in the dorsal medial 
prefrontal cortex x,y,z=14,–8,52, t=5·09, p[FWE–cluster 
level]=0·0002; dorsal ROI p[FWE–cluster level]=0·0023); 
rostral ROI p[uncorrected]=0·001)), but crucially—since 
this is confounded by group eﬀ ects—saw a correlation 
with trait anxiety in the patient group alone (dorsal peak 
x,y,z=–8,10,30, t=4·6, p[uncorrected]<0·0001) (ﬁ gure 3A). 
Moreover, we recorded no correlations with depression 
ratings (on the BDI) across the whole group or within the 
patients with anxiety disorders alone (all p>0·2), which 
indicates that this eﬀ ect was speciﬁ c to anxiety symptoms.
Event-related analysis conﬁ rmed that the amygdala and 
the dorsal medial prefrontal cortex were signiﬁ cantly active 
in both patients with anxiety disorders and healthy controls 
across all participants (all trials vs baseline within ROIs: 
rostral x,y,z=–2,2,–50; t=4·01, p[FWE–voxel]=0·013; dorsal 
x,y,z=2,8,56, t=3·88; p[uncorrected]=0·0002; amygdala 
Cluster 
size (k)
t test 
value 
Automated anatomical label26
4,–8,32 99 4·69 Right dorsal anterior cingulate cortex
–4,–6,36 † 4·14 Left dorsal anterior cingulate cortex
6,0,34 † 3·68 Right dorsal anterior cingulate cortex
20,–10,34 127 4·65 Right dorsal anterior cingulate cortex
30,–4,40 † 4·64 Right precentral cortex
22,–6,44 † 4·62 Right precentral cortex
–28,–14,26 46 4·58 Left insula
–30,–4,32 † 3·93 Left precentral cortex
–26,–22,26 † 3·83 Left caudate
–66,–26,2 35 4·46 Left middle temporal cortex
–16,44,–6 17 4·39 Left ventral anterior cingulate
–14,–30,48 10 4·37 Left dorsal caudal cingulate
34,–62,16 14 4·29 Right calacrine ﬁ ssure
–26,16,52 38 4·19 Left dorsal medial frontal cortex
–18,22,46 † 3·43 Left dorsal medial frontal cortex
–12,22,4 23 4·18 Left caudate
–30,38,–4 12 4·08 Left inferior orbitofrontal cortex
–52 37 4·06 Cerebellum
–36,–34,30 13 4·03 Left inferior parietal cortex
40,–30,6 4 4 Left superior temporal gyrus
28,10,28 13 3·96 Left inferior frontal cortex
–26,0,26 3 3·96 Left caudate
26,–20,32 5 3·9 Right caudate
34,–4,38 2 3·88 Right precentral cortex
20,12,34 3 3·84 Right medial cingulate
–10,–26,44 4 3·82 Left medial cingulate
0,6,8 7 3·81 Left caudate
18,16,14 3 3·79 Right caudate
–34,–66,6 3 3·69 Left medial occipital cortex
0,12,34 22 3·69 Left medial cingulate
–14,28,8 2 3·6 Left caudate
–16,50,16 6 3·6 Left superior frontal gyrus
48,14,28 2 3·57 Right inferior frontal gyrus
42,–14,–10 2 3·54 Right insula
26,–52,14 2 3·54 Right calcarine ﬁ ssure
36,–48,34 2 3·53 Right inferior parietal cortex
–50,24,36 5 3·52 Left medial frontal cortex
–58 6 3·46 Left superior temporal gyrus
14,40,42 2 3·44 Right superior frontal cortex
*Interactions presented are signiﬁ cant at p≤0·001 uncorrected at the whole brain 
level. †Each of these peaks fall within the larger cluster above.
Table 2: Clusters showing signiﬁ cant connectivity with the amygdala in 
the diagnosis-by-valence interaction*, by Montreal Neurological 
Institute coordinates (x,y,z)
Articles
www.thelancet.com/psychiatry   Vol 1  September 2014 299
x,y,z=28,–2,12, t=5·09, p[FWE–voxel]<0·0001). However, 
when we broke this analysis down into groups (ie, healthy 
participants and those with anxiety disorders), no signiﬁ cant 
interaction with groups was noted (rostral: diagnosis-by-
valence x,y,z=–2,4,30, t=1·7, p[uncorrected]=0·045; dorsal: 
x,y,z=–2,2,28, t=1·9, p[uncorrected]=0·029; amygdala 
valence-by-diagnosis p>0·4). Exploratory whole-brain event-
related activation interactions are presented in the appendix. 
SPSS general linear models of estimates extracted from 
the a priori peak voxel showed no signiﬁ cant diﬀ erences 
on variables of interest across DSM subdiagnoses 
(valence [ fear, happy] by diagnosis [ie, generalised anxiety 
disorder, social anxiety disorder, both generalised and 
social anxiety disorder, or healthy] interaction: F[3,41]=2·2, 
p=0·1, partial eta² 0·1 [95% CI 0·00–0·29]; main eﬀ ect of 
diagnosis p<0·2). 
Restriction of the primary analyses to a primary diagnosis 
of generalised anxiety disorder (ie, including all patients 
with generalised anxiety disorder and those with comorbid 
generalised anxiety disorder and social anxiety disorder 
[n=15] but excluding those with social anxiety disorder 
only) replicated the whole-group eﬀ ects (dorsal peak vs 
trait anxiety: x,y,z=4,–8,38, t=3·88, p[uncorrected]<0·001; 
1-tailed test of x,y,z=2,2,40 vs trait anxiety: r[38]=0·3, 
p=0·04]). Thus, traditional subdiagnoses are not suﬃ  cient 
to explain the neurobiological abnormality in patients with 
anxiety disorders.
Task accuracy (correct identiﬁ cation of face emotion)
was 81% across the whole study population, with a mean 
reaction time of 705 ms (SD 72) for happy faces and 
708 ms (SD 71) for fearful faces across both groups. 
Valence had no signiﬁ cant eﬀ ect on reaction time across 
the sample overall (fear vs happy reaction time t[44]=0·4, 
p=0·7) or on a group-by-valence interaction in reaction 
time (p=0·14). However, in support of a brain–behaviour 
association, whole-brain analysis of all participants 
showed a peak in the dorsal anterior cingulate cortex 
driven by a signiﬁ cant negative association between fear 
and happy connectivity and fear versus happy reaction 
time (x,y,z=0,12,22; t=4; p[uncorrected]=0·0001). In other 
words, greater connectivity during the processing of 
fearful faces than happy faces was associated with a 
faster response to fearful faces than to happy faces.
Discussion
This study conﬁ rmed our hypothesis that engagement 
of the aversive ampliﬁ cation circuit—recruited during 
stress in healthy individuals in our previous studies7,9—
would be increased in the absence of shock threat in 
the context of pathological anxiety. Speciﬁ cally, we 
show increased positive coupling within the dorsal 
medial prefrontal (anterior cingulate) cortex–amygdala 
circuit during fearful face processing in patients with 
generalised and social anxiety disorders. Moreover, we 
show that this increased coupling follows a continuum 
of trait anxiety, with the patients showing greatest 
coupling also presenting with the most severe 
symptoms. This eﬀ ect overlaps the peaks emphasised 
in our previous study,7 thus, we show the existence of a 
circuit that contributes to both adaptive anxiety 
responses and, when chronically activated, to 
maladaptive responses—a prerequisite for a more 
mechanistic, neurobiologically rooted diagnosis and 
treatment of pathological anxiety (panel).
We have previously called this circuit an aversive 
ampliﬁ cation circuit in accordance with ﬁ ndings from 
studies in rodents. These have shown the prelimbic 
prefrontal cortex to drive amygdala activity and lead to 
increased responses to fear.10 In people, dorsal regions of 
the prefrontal cortext and anterior cingulate cortex have 
been argued to represent the human functional 
homologues of this region.30,31 Previous work across 
several anxiety disorders has, for example, conﬁ rmed 
hyperactivity in the dorsal medial prefrontal cortex or 
dorsal anterior cingulate cortex or the amygdala in simple 
event-related studies.5,18,19,32,33 Indeed, the studies by Milad 
and colleagues30 and Mechias and colleagues19 show a 
similar pattern to both our current and previous ﬁ ndings7 
of a larger more posterior cluster and a smaller more 
rostral prefrontal cluster. In these studies, the function of 
Figure 3: Continuous variable analysis
(A) Group map of the regions in the brain that correlate with trait anxiety for 
the fear vs happy contrast. (B) Whole-brain positive correlation with trait 
anxiety scores: dorsal medial prefrontal cortex–amygdala coupling falls along 
a continuum of self-reported anxiety symptoms within the patient group. 
Data extracted from a priori peak (x,y,z=2,2,40) in the patient group for 
illustrative purposes. 
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these regions is argued to be in fear conditioning and 
conscious appraisal of threats, respectively—both of 
which align well with our proposed circuit function. The 
present study employs connectivity analysis to study the 
coupling between this dorsal region and the amygdala in 
a circuit in pathological anxiety. This approach is 
important because coupling is thought to represent a 
distinct informational process relative to activation, 
which speciﬁ cally represents the ﬂ ow of information and 
attentional processes.20 It is not that these regions are any 
more or less eﬃ  cient at processing information in the 
pathological disorder; rather, the extent to which they 
communicate is changed. 
Our ﬁ ndings therefore allow us to map a potential neural 
pathway for a key symptom that unites anxiety disorders, 
namely chronically increased threat processing. The 
amygdala might detect threats, but the dorsal medial 
prefrontal (anterior cingulate) cortex could be a central 
node of a broader anxiety circuit, playing a key part in 
integration of threat information and orchestration of 
response expression through synchronised activity with 
distant brain regions. Thus, this circuit is activated in 
stressful environments (eg, shock anticipation7) to promote 
the adaptive34 detection of threatening stimuli (at the 
expense of non-threatening stimuli [Vytal K, unpublished]). 
In healthy people under innocuous circumstances, mild 
threats (eg, fearful faces) do not increase dorsal medial 
prefrontal cortex–amygdala coupling, but in pathological 
anxiety this circuit becomes permanently switched on, 
even in innocuous contexts, and contributes to a crippling 
focus upon negative life experiences. Of course, this is not 
the only symptom characteristic of pathological anxiety, 
but it is a core feature that perhaps uniﬁ es both adaptive 
and pathological anxiety.
Our ability to map a potential symptom pathway from 
adaptive to maladaptive states supports the clinical 
potential of this circuit. First, from a diagnostic per-
spective, we show that neural circuit engagement exists 
along a continuum as a function of self-reported symptoms, 
and irrespective of the traditional DSM-deﬁ ned diagnosis 
of generalised or social anxiety disorder. Psychiatry is the 
only branch of medicine in which diagnosis is 
predominantly based upon self-reported symptoms rather 
than underlying mechanisms; the present ﬁ ndings provide 
the potential beginnings of a dimensional, mechanistic 
anxiety index with diagnostic value.21,35 Anxiety disorder 
subtypes are highly comorbid36,37 and our present data are 
consistent with the assumption that this is because, at least 
as far as generalised and social anxiety disorders go, the 
neural circuit underlying a core symptom of anxiety 
disorders—a bias towards threats—falls along a diagnosis-
independent continuum. Such a scale could comprise a 
row of the “negative valence symptoms” category of the 
Research Domains Criteria matrix35,38 which seeks to create 
biologically informed psychiatric diagnoses. Future work 
with a much larger sample of individuals, a broader range 
of anxious traits, and undertaken across several sites will 
be the next step towards translation of this ﬁ nding into a 
clinically useful measure.
Second, our previous work with this circuit provides a 
mechanism by which we might be able to target 
treatments. The direction of correlation between 
symptom severity and circuit engagement suggests that 
we should attempt to disrupt activity within this circuit. 
We have, in fact, shown this circuit to be inhibited by 
Panel: Research in context
Systematic review
This study was part of a programmatic sequence of studies 
and takes its main inspiration from these previous works. 
However, inspiration was also drawn from translational 
animal work10,30,31 and both original trials and review papers 
exploring activity within the studied brain regions in both 
patients and healthy populations.2–5,17–19,32,33 Further inspiration 
was drawn from data (again from both original studies and 
reviews) exploring connectivity within this circuit13 and a 
related ventral circuit11–15 in both patients and healthy 
controls. Relevant articles were identiﬁ ed through searches of 
PubMed and Google Scholar including combinations of the 
terms “anxiety”, “stress”, “anxiety disorders”, “GAD”, “social 
anxiety”, “PPI”, “fMRI”, “connectivity”, “amygdala“,“coupling“, 
“dACC“,“dmPFC“ in August, 2013. Our search was of the 
entire PubMed catalogue (from start until present) and we 
included articles published in English only. To the best of our 
knowledge, this study is the ﬁ rst to explore connectivity 
within this circuit across social or generalised anxiety disorder 
and healthy controls.
Interpretation
The present data, together with our previous work, suggest 
that a common mechanism, namely positive dorsal medial 
prefrontal cortex–amygdala coupling during aversive 
processing, might underlie both healthy stress responses and 
social and generalised anxiety disorders. Moreover, this 
mechanism might track subjective anxiety symptoms such 
that increased recruitment of this circuit is associated with 
greater self-reported trait anxiety. Although this report is 
early experimental work, the ﬁ ndings have two potential 
clinical implications. First, this study is a step away from 
categorical diagnoses based on symptoms and towards a 
more continuum-based, mechanistic understanding of 
anxiety pathology. Speciﬁ cally, the data provide experimental 
support for the idea that anxiety subtypes might share 
overlapping neurobiological abnormalities that fall along a 
continuous scale from adaptive to pathological. Second, from 
a clinical perspective, these data might ultimately help to 
target treatments. We have shown this circuit to be 
modulated by serotonin and as such we provide a potential 
mechanism by which such drugs enact their anxiolytic 
properties. This could, in turn, provide a potential means of 
identifying individuals who will respond to such treatments 
(eg, patients who would be better suited to psychological or 
pharmacological interventions).
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serotonin,8 such that serotonin reduction serves to 
increase activity within this circuit during the 
processing of fearful faces. Thus, selective serotonin 
reuptake inhibitors could restore inhibition of this 
circuit,39 reducing responses to aversive stimuli. Such an 
understanding is key because, despite the widespread 
use of selective serotonin reuptake inhibitor drugs, our 
understanding of their mechanism of action is far from 
adequate,39 leading to ineﬃ  cient prescription. Perhaps 
this circuit will provide a means of recognising patients 
who will respond positively to treatment. In a specialty 
in which a large proportion of patients do not respond to 
their ﬁ rst treatment, even a small increase in success 
rate would be beneﬁ cial.
Future work can therefore ask: what interventions—
pharmacological or psychological—can serve to attenuate 
activity within this circuit during aversive processing? 
Evidence suggests, for example, that cognitive-based 
treatments can target nodes within this circuit.40 One of 
the biggest impediments to treatment development is the 
failure of animal screens to scale up to human beings and 
a lack of naturalistic human screening markers.1,41 Since 
we have shown that this circuit can be safely and reversibly 
activated in healthy individuals,8 while simultaneously 
linking it to clinical presentation, we might be able to use 
provocation of this circuit as a screen for more targeted 
assessment of candidate anxiolytics.1,42
To show the validity of our ﬁ ndings from several angles, 
we obtained traditional subtype diagnoses. This analysis 
replicated key eﬀ ects independent of subdiagnosis, but it 
should be noted that our naturalistic sample contained 
fewer people with a diagnosis of social anxiety disorder 
alone. Additional analyses suggested that this did not 
unduly aﬀ ect the overall ﬁ ndings, but extra caution 
should be exercised in drawing conclusions about this 
particular subgroup because of the sample size. 
Moreover, and importantly, we are not arguing that this 
is the sole role of this circuit and, furthermore, we are 
somewhat agnostic regarding naming the prefrontal 
region (eg, dorsal medial prefrontal cortex vs dorsal 
anterior cingulate cortex). What is crucial is that we have 
noted an overlapping pattern across several studies 
examining anxiety-related processes using matched tasks.
In conclusion, this study shows engagement of the dorsal 
medial prefrontal (anterior cingulate) cortex–amygdala 
circuit during aversive processing in pathological anxiety. A 
detailed understanding of the relation between neural 
circuitry and such core anxiety symptoms is, we argue, a 
prerequisite for more targeted diagnosis and treatments. 
We hope that this study represents a ﬁ rst step towards a 
more mechanistic and dimensional understanding of the 
pathology underlying anxiety disorders.
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